Alzheimer's Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis
Alzheimer's disease (AD) is a central nervous system (CNS) disease characterized by loss of memory, cognitive functions, and neurodegeneration. Plasmin is an enzyme degrading many plasma proteins. In the CNS, plasmin may reduce the accumulation of beta amyloid (Aβ) and have other actions releva...
Saved in:
Main Authors: | Francesco Angelucci (Author), Katerina Veverova (Author), Alžbeta Katonová (Author), Lydia Piendel (Author), Martin Vyhnalek (Author), Jakub Hort (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?
by: Francesco Angelucci, et al.
Published: (2019) -
Calycosin ameliorates osteoarthritis by regulating the imbalance between chondrocyte synthesis and catabolism
by: Hong Su, et al.
Published: (2024) -
A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity
by: Yutaka Kakizoe, et al.
Published: (2016) -
A unique group of scabies mite pseudoproteases promotes cutaneous blood coagulation and delays plasmin-induced fibrinolysis.
by: Deepani D Fernando, et al.
Published: (2021) -
Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022)